已收盤 12-12 16:00:00 美东时间
-0.030
-0.15%
Shareholders to Receive $21.20 Per Share in Cash Representing a 40.0% Premium to Closing Price on December 8, 2025HONOLULU, Dec. 8, 2025 /PRNewswire/ -- Alexander & Baldwin, Inc., (NYSE:ALEX) ( "A&B" or the
12-09 06:33
今日重点评级关注:摩根士丹利:维持Kyverna Therapeutics"超配"评级,目标价从20美元升至25美元;Maxim Group:维持Capricor Therapeutics"买入"评级,目标价从25美元升至50美元
12-05 08:35
Realty Income Increases 2025 Investment Volume Guidance to Over $6.0 BillionSAN DIEGO and NEW YORK, Dec. 1, 2025 /PRNewswire/ -- Realty Income Corporation ((Realty Income, NYSE:O), The Monthly Dividend Company® and
12-02 05:42
今日重点评级关注:HC Wainwright & Co.:维持Oncolytics Biotech"买入"评级,目标价从5美元升至10美元;HC Wainwright & Co.:维持Barinthus Biotherapeutics"买入"评级,目标价从3美元升至4美元
11-18 15:28
Keefe, Bruyette & Woods analyst Jade Rahmani upgrades Blackstone Mortgage Trust (NYSE:BXMT) from Market Perform to Outperform and raises the price target from $20 to $21.
11-17 18:29
今日重点评级关注:Ascendiant Capital:维持NRX Pharmaceuticals"买入"评级,目标价从46美元升至47美元;富国银行:维持Kyverna Therapeutics"超配"评级,目标价从27美元升至31美元
10-31 10:25
JP Morgan analyst Richard Shane maintains Blackstone Mortgage Trust (NYSE:BXMT) with a Neutral and raises the price target from $18.5 to $19.
10-31 04:44
Companies Reporting Before The Bell • OppFi (NYSE:OPFI) is expected to report q...
10-29 19:11
今日重点评级关注:HC Wainwright & Co.:维持Inventiva"买入"评级,目标价从20美元升至24美元;摩根大通:维持BioMarin Pharmaceutical"超配"评级,目标价从116美元升至119美元
10-10 11:36
Keefe, Bruyette & Woods analyst Jade Rahmani maintains Blackstone Mortgage Trust (NYSE:BXMT) with a Market Perform and raises the price target from $19.5 to $20.
10-10 00:59